Related Experiment Videos
Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma
Mateja M Marc1, Peter Korosec, Mitja Kosnik
1University Clinic of Respiratory and Allergic Diseases, Golnik 36, 4204 Golnik, Slovenia. mateja.marc@klinika-golnik.si
American Journal of Respiratory Cell and Molecular Biology
|March 25, 2004
Summary
Complement factor C5a is elevated in the airways of patients with chronic obstructive pulmonary disease (COPD) and asthma, suggesting its role in the inflammation and pathogenesis of these respiratory diseases.
Area of Science:
- Immunology
- Pulmonology
- Complement System
Background:
- Complement system activation is implicated in COPD and asthma pathogenesis.
- Animal models suggest a role in inflammation and airway hyperresponsiveness.
Purpose of the Study:
- To investigate C3a, C4a, and C5a levels in induced sputum of COPD and asthma patients.
- To determine if these complement factors are elevated at the site of airway inflammation.
Main Methods:
- Induced sputum analysis from COPD patients, asthma patients, and healthy controls.
- Cytometric bead array used to measure anaphylatoxin concentrations.
- Correlation analysis between C5a levels and lung diffusion capacity in COPD.
Main Results:
- Significantly elevated C5a concentrations found in COPD and asthma patients compared to controls.
- No significant differences in C3a or C4a levels between groups.
- Negative correlation between C5a levels and lung diffusion coefficient in COPD patients.
Conclusions:
- Complement factor C5a is involved in the pathogenesis of COPD and asthma.
- C5a may be a key mediator in the inflammatory processes of these diseases.